{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:13:16Z","timestamp":1779930796162,"version":"3.53.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["403615\/2023\u20132"],"award-info":[{"award-number":["403615\/2023\u20132"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02090-9","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T10:14:27Z","timestamp":1758017667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cannabinoids in preclinical research of sepsis: a scoping review"],"prefix":"10.1007","volume":"74","author":[{"given":"Carolina Henkes","family":"Inamassu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Sordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila","family":"Marchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"issue":"5","key":"2090_CR1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/pharmrev.122.000600","volume":"75","author":"M Maccarrone","year":"2023","unstructured":"Maccarrone M, Di Marzo V, Gertsch J, et al. Goods and bads of the endocannabinoid system as a therapeutic target: lessons learned after 30 years. Pharmacol Rev. 2023;75(5):885\u2013958.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"2090_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.beem.2008.10.013","volume":"23","author":"L De Petrocellis","year":"2009","unstructured":"De Petrocellis L, Di Marzo V. An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract Res Clin Endocrinol Metab. 2009;23(1):1\u201315.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3 Suppl","key":"2090_CR3","first-page":"3","volume":"29","author":"NM Kogan","year":"2006","unstructured":"Kogan NM, Mechoulam R. The chemistry of endocannabinoids. J Endocrinol Invest. 2006;29(3 Suppl):3\u201314.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2090_CR4","first-page":"607","volume":"6","author":"HC Lu","year":"2021","unstructured":"Lu HC, Mackie K. Review of the endocannabinoid system. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6):607\u201315.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"3","key":"2090_CR5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","volume":"160","author":"BK Atwood","year":"2010","unstructured":"Atwood BK, Mackie K. CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol. 2010;160(3):467\u201379.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"2090_CR6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000641","volume":"2","author":"S Jiang","year":"2007","unstructured":"Jiang S, Fu Y, Williams J, et al. Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells. PLoS ONE. 2007;2(7):e641.","journal-title":"PLoS ONE"},{"issue":"9","key":"2090_CR7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/sj.cdd.4401284","volume":"10","author":"M Maccarrone","year":"2003","unstructured":"Maccarrone M, Finazzi-Agr\u00f3 A. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ. 2003;10(9):946\u201355.","journal-title":"Cell Death Differ"},{"issue":"8","key":"2090_CR8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"3","key":"2090_CR9","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare6030090","volume":"6","author":"J Hajj","year":"2018","unstructured":"Hajj J, Blaine N, Salavaci J, Jacoby D. The, \u201ccentrality of sepsis\u201d: a review on incidence, mortality, and cost of care. Healthcare. 2018;6(3):90.","journal-title":"Healthcare"},{"issue":"1","key":"2090_CR10","first-page":"53","volume":"49","author":"G Polat","year":"2017","unstructured":"Polat G, Ugan RA, Cadirci E, Halici Z. Sepsis and septic shock: current treatment strategies and new approaches. Eurasian J Med. 2017;49(1):53.","journal-title":"Eurasian J Med"},{"issue":"4","key":"2090_CR11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","volume":"20","author":"JC Marshall","year":"2014","unstructured":"Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med. 2014;20(4):195\u2013203.","journal-title":"Trends Mol Med"},{"issue":"4","key":"2090_CR12","first-page":"191","volume":"1","author":"N Ladak","year":"2011","unstructured":"Ladak N, Beishon L, Thompson JP, Lambert DG. Cannabinoids and sepsis. Trends Anaesth Crit Care. 2011;1(4):191\u20138.","journal-title":"Trends Anaesth Crit Care"},{"issue":"1","key":"2090_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.22514\/SV61.052011.1","volume":"6","author":"C Lehmann","year":"2011","unstructured":"Lehmann C, Kianian M, Zhou J, et al. The endocannabinoid system in sepsis\u2013a potential target to improve microcirculation? Signa Vitae. 2011;6(1):7\u201313.","journal-title":"Signa Vitae"},{"issue":"5","key":"2090_CR14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/SHK.0000000000001763","volume":"56","author":"MCG Leite-Avalca","year":"2021","unstructured":"Leite-Avalca MCG, Zampronio A, Lehmann C. Cannabinoid receptor 1 and 2 signaling pathways involved in sepsis. Shock. 2021;56(5):673\u201381.","journal-title":"Shock"},{"issue":"4","key":"2090_CR15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/HYPERTENSIONAHA.105.063651","volume":"52","author":"P Pacher","year":"2008","unstructured":"Pacher P, Mukhopadhyay P, Mohanraj R, et al. Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. Hypertension. 2008;52(4):601\u20137.","journal-title":"Hypertension"},{"issue":"4","key":"2090_CR16","doi-asserted-by":"crossref","DOI":"10.3390\/metabo7040055","volume":"7","author":"JD Lafreniere","year":"2017","unstructured":"Lafreniere JD, Lehmann C. Parameters of the endocannabinoid system as novel biomarkers in sepsis and septic shock. Metabolites. 2017;7(4):55.","journal-title":"Metabolites"},{"issue":"7","key":"2090_CR17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"2090_CR18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-4613-0407-4_15","volume":"402","author":"TW Klein","year":"1996","unstructured":"Klein TW, Newton C, Friedman H. Cannabinoids and immunity to Legionella pneumophila infection. AIDS, Drugs of Abuse, and the Neuroimmune Axis. 1996;402:103\u20139.","journal-title":"AIDS, Drugs of Abuse, and the Neuroimmune Axis"},{"issue":"11","key":"2090_CR19","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1096\/fasebj.12.11.1035","volume":"12","author":"K Varga","year":"1998","unstructured":"Varga K, Wagner JA, Bridgen DT, et al. Platelet-and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J. 1998;12(11):1035\u201344.","journal-title":"FASEB J"},{"issue":"5","key":"2090_CR20","doi-asserted-by":"crossref","first-page":"H2280","DOI":"10.1152\/ajpheart.00851.2004","volume":"288","author":"SM Gardiner","year":"2005","unstructured":"Gardiner SM, March JE, Kemp PA, et al. Involvement of CB1-receptors and \u03b2-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats. American Journal of Physiology-Heart and Circulatory Physiology. 2005;288(5):H2280\u20138.","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"issue":"11","key":"2090_CR21","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1097\/01.CCM.0000187010.14426.CC","volume":"33","author":"Y Kadoi","year":"2005","unstructured":"Kadoi Y, Hinohara H, Kunimoto F, et al. Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats. Crit Care Med. 2005;33(11):2629\u201336.","journal-title":"Crit Care Med"},{"issue":"5","key":"2090_CR22","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/bja\/aei106","volume":"94","author":"Y Kadoi","year":"2005","unstructured":"Kadoi Y, Hinohara H, Kunimoto F, et al. Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats. Br J Anaesth. 2005;94(5):563\u20138.","journal-title":"Br J Anaesth"},{"issue":"3","key":"2090_CR23","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1124\/jpet.106.113159","volume":"320","author":"K Benamar","year":"2007","unstructured":"Benamar K, Yondorf M, Meissler JJ, et al. A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide. J Pharmacol Exp Ther. 2007;320(3):1127\u201333.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20133","key":"2090_CR24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejphar.2007.03.032","volume":"566","author":"ML Orliac","year":"2007","unstructured":"Orliac ML, Peroni RN, Abramoff T, et al. Increases in vanilloid TRPV1 receptor protein and CGRP content during endotoxemia in rats. Eur J Pharmacol. 2007;566(1\u20133):145\u201352.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"2090_CR25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2982.2008.01114.x","volume":"20","author":"D De Filippis","year":"2008","unstructured":"De Filippis D, Iuvone T, D\u2019amico A, et al. Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB1 receptors and fatty acid amide hydrolase. Neurogastroenterol Motil. 2008;20(8):919\u201327.","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"2090_CR26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00540-008-0610-x","volume":"22","author":"T Hashiguchi","year":"2008","unstructured":"Hashiguchi T, Kakihana Y, Isowaki S, et al. Systematic evaluation of nitric oxide, tetrahydrobiopterin, and anandamide levels in a porcine model of endotoxemia. J Anesth. 2008;22(3):213\u201320.","journal-title":"J Anesth"},{"issue":"5","key":"2090_CR27","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1399-6576.2007.01573.x","volume":"52","author":"Y Kadoi","year":"2008","unstructured":"Kadoi Y, Hinohara H, Kunimoto F, et al. Effects of the cannabinoid antagonist AM281 on systemic hemodynamics and mortality rate in streptozotocin-induced diabetic rats with endotoxic shock: comparison between non-diabetic and diabetic rats. Acta Anaesthesiol Scand. 2008;52(5):664\u201372.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"4","key":"2090_CR28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.bjp.0705839","volume":"142","author":"G Godlewski","year":"2004","unstructured":"Godlewski G, Malinowska B, Schlicker E. Presynaptic cannabinoid CB1 receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats. Br J Pharmacol. 2004;142(4):701\u20138.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"2090_CR29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006409","volume":"4","author":"B Cs\u00f3ka","year":"2009","unstructured":"Cs\u00f3ka B, N\u00e9meth ZH, Mukhopadhyay P, et al. CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis. PLoS ONE. 2009;4(7):e6409.","journal-title":"PLoS ONE"},{"issue":"1","key":"2090_CR30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.0900203","volume":"183","author":"J Tsch\u00f6p","year":"2009","unstructured":"Tsch\u00f6p J, Kasten KR, Nogueiras R, et al. The cannabinoid receptor 2 is critical for the host response to sepsis. J Immunol. 2009;183(1):499\u2013505.","journal-title":"J Immunol"},{"issue":"7","key":"2090_CR31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.placenta.2009.04.003","volume":"30","author":"CA Vercelli","year":"2009","unstructured":"Vercelli CA, Aisemberg J, Billi S, et al. Endocannabinoid system and nitric oxide are involved in the deleterious effects of lipopolysaccharide on murine decidua. Placenta. 2009;30(7):579\u201384.","journal-title":"Placenta"},{"issue":"6","key":"2090_CR32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/SHK.0b013e3181a4fd8f","volume":"32","author":"A Villanueva","year":"2009","unstructured":"Villanueva A, Yilmaz SM, Millington WR, et al. Central cannabinoid 1 receptor antagonist administration prevents endotoxic hypotension affecting norepinephrine release in the preoptic anterior hypothalamic area. Shock. 2009;32(6):614\u201320.","journal-title":"Shock"},{"key":"2090_CR33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2010.06.023","volume":"1348","author":"OJ Cassol-Jr","year":"2010","unstructured":"Cassol-Jr OJ, Comim CM, Silva BR, et al. Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture. Brain Res. 2010;1348:128\u201338.","journal-title":"Brain Res"},{"issue":"1","key":"2090_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-8-5","volume":"8","author":"L Ruiz-Valdepe\u00f1as","year":"2011","unstructured":"Ruiz-Valdepe\u00f1as L, Mart\u00ednez-Orgado JA, Benito C, et al. Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study. J Neuroinflammation. 2011;8(1):5.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"2090_CR35","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1113\/jphysiol.2010.202465","volume":"589","author":"AA Steiner","year":"2011","unstructured":"Steiner AA, Molchanova AY, Dogan MD, et al. The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors. J Physiol. 2011;589(9):2415\u201331.","journal-title":"J Physiol"},{"issue":"2","key":"2090_CR36","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/cc11248","volume":"16","author":"C Lehmann","year":"2012","unstructured":"Lehmann C, Kianian M, Zhou J, et al. Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis. Crit Care. 2012;16(2):R47.","journal-title":"Crit Care"},{"issue":"6","key":"2090_CR37","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1213\/ANE.0b013e318251dada","volume":"114","author":"I K\u00fcster","year":"2012","unstructured":"K\u00fcster I, Kuschnereit R, Kelly M, et al. Cannabinoid receptor 1 inhibition causes seizures during anesthesia induction in experimental sepsis. Anesth Analg. 2012;114(6):1217\u20139.","journal-title":"Anesth Analg"},{"issue":"1","key":"2090_CR38","volume":"2013","author":"H Gui","year":"2013","unstructured":"Gui H, Sun Y, Luo ZM, et al. Cannabinoid receptor 2 protects against acute experimental sepsis in mice. Mediators Inflamm. 2013;2013(1):741303.","journal-title":"Mediators Inflamm"},{"key":"2090_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-14-1","volume":"14","author":"MW Liu","year":"2014","unstructured":"Liu MW, Su MX, Wang YH, et al. Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats. BMC Complement Altern Med. 2014;14:1\u201312.","journal-title":"BMC Complement Altern Med"},{"key":"2090_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-11-108","volume":"11","author":"S Redlich","year":"2014","unstructured":"Redlich S, Ribes S, Sch\u00fctze S, Nau R. Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections. J Neuroinflammation. 2014;11:1\u201311.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"2090_CR41","volume":"2014","author":"J Sardinha","year":"2014","unstructured":"Sardinha J, Kelly MEM, Zhou J, et al. Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis. Mediators Inflamm. 2014;2014(1):978678.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"2090_CR42","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3233\/CH-151996","volume":"61","author":"JT Toguri","year":"2015","unstructured":"Toguri JT, Moxsom R, Szczesniak AM, et al. Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusion in the iridial microvasculature during systemic inflammation. Clin Hemorheol Microcirc. 2015;61(2):237\u201349.","journal-title":"Clin Hemorheol Microcirc"},{"issue":"3","key":"2090_CR43","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/SHK.0000000000000598","volume":"46","author":"MCG Leite-Avalca","year":"2016","unstructured":"Leite-Avalca MCG, Lomba LA, Bastos-Pereira AL, et al. Involvement of central endothelin ETA and cannabinoid CB1 receptors and arginine vasopressin release in sepsis induced by cecal ligation and puncture in rats. Shock. 2016;46(3):290\u20136.","journal-title":"Shock"},{"key":"2090_CR44","doi-asserted-by":"crossref","first-page":"4315412","DOI":"10.1155\/2017\/4315412","volume":"2017","author":"TS Kapellos","year":"2017","unstructured":"Kapellos TS, Recio C, Greaves DR, Iqbal AJ. Cannabinoid receptor 2 modulates neutrophil recruitment in a murine model of endotoxemia. Mediators Inflamm. 2017;2017:4315412.","journal-title":"Mediators Inflamm"},{"key":"2090_CR45","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.pharep.2018.07.001","volume":"70","author":"P Singh","year":"2018","unstructured":"Singh P, Sharma P, Nakade UP, et al. Endocannabinoid-mediated modulation of Gq protein-coupled receptor mediates vascular hyporeactivity to nor-adrenaline during polymicrobial sepsis. Pharmacol Rep. 2018;70:1150\u20137.","journal-title":"Pharmacol Rep"},{"issue":"2","key":"2090_CR46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s10753-018-0919-z","volume":"42","author":"MCG Leite-Avalca","year":"2019","unstructured":"Leite-Avalca MCG, Staats FT, Verona D, et al. Cannabinoid CB1 receptor antagonist rimonabant decreases levels of markers of organ dysfunction and alters vascular reactivity in aortic vessels in late sepsis in rats. Inflammation. 2019;42(2):618\u201327.","journal-title":"Inflammation"},{"key":"2090_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105978","volume":"78","author":"M \u00c7akir","year":"2020","unstructured":"\u00c7akir M, Tekin S, Okan A, et al. The ameliorating effect of cannabinoid type 2 receptor activation on brain, lung, liver and heart damage in cecal ligation and puncture-induced sepsis model in rats. Int Immunopharmacol. 2020;78:105978.","journal-title":"Int Immunopharmacol"},{"issue":"7","key":"2090_CR48","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ddr.21706","volume":"81","author":"Q Jiang","year":"2020","unstructured":"Jiang Q, Chen Z, Jiang H. Flufenamic acid alleviates sepsis-induced lung injury by up-regulating CBR1. Drug Dev Res. 2020;81(7):885\u201392.","journal-title":"Drug Dev Res"},{"issue":"12","key":"2090_CR49","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.2000213","volume":"204","author":"J Joffre","year":"2020","unstructured":"Joffre J, Yeh CC, Wong E, et al. Activation of CB1R promotes lipopolysaccharide-induced IL-10 secretion by monocytic myeloid-derived suppressive cells and reduces acute inflammation and organ injury. J Immunol. 2020;204(12):3339\u201350.","journal-title":"J Immunol"},{"key":"2090_CR50","volume":"69","author":"AP Liu","year":"2020","unstructured":"Liu AP, Yuan QH, Zhang B, et al. Cannabinoid receptor 2 activation alleviates septic lung injury by promoting autophagy via inhibition of inflammatory mediator release. Cell Signal. 2020;69:109556.","journal-title":"Cell Signal"},{"key":"2090_CR51","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.644281","volume":"12","author":"M Sultan","year":"2021","unstructured":"Sultan M, Alguetaa H, Mohammed A, et al. The endocannabinoid anandamide attenuates acute respiratory distress syndrome by downregulating miRNA that target inflammatory pathways. Front Pharmacol. 2021;12:644281.","journal-title":"Front Pharmacol"},{"key":"2090_CR52","volume":"99","author":"B Zhang","year":"2021","unstructured":"Zhang B, Zheng F, Liu A, et al. Activation of CB2 receptor inhibits pyroptosis and subsequently ameliorates cecal ligation and puncture-induced sepsis. Int Immunopharmacol. 2021;99:108038.","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"2090_CR53","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.4049\/jimmunol.2101015","volume":"208","author":"J Chen","year":"2022","unstructured":"Chen J, Wang F, Zhang S, et al. Activation of CD4+ T cell\u2013derived cannabinoid receptor 2 signaling exacerbates sepsis via inhibiting IL-10. J Immunol. 2022;208(11):2515\u201322.","journal-title":"J Immunol"},{"issue":"5","key":"2090_CR54","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3892\/mmr.2022.12671","volume":"25","author":"R Chen","year":"2022","unstructured":"Chen R, Xu H, Guo Z, et al. CID16020046, a GPR55 antagonist, attenuates sepsis-induced acute kidney injury. Mol Med Rep. 2022;25(5):155.","journal-title":"Mol Med Rep"},{"issue":"24","key":"2090_CR55","doi-asserted-by":"crossref","first-page":"15857","DOI":"10.3390\/ijms232415857","volume":"23","author":"S Hall","year":"2022","unstructured":"Hall S, Faridi S, Trivedi P, et al. Selective CB2 receptor agonist, HU-308, reduces systemic inflammation in endotoxin model of pneumonia-induced acute lung injury. Int J Mol Sci. 2022;23(24):15857.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2090_CR56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12974-022-02485-z","volume":"19","author":"J Joffre","year":"2022","unstructured":"Joffre J, Wong E, Lawton S, et al. N-oleoyl dopamine induces IL-10 via central nervous system TRPV1 and improves endotoxemia and sepsis outcomes. J Neuroinflammation. 2022;19(1):118.","journal-title":"J Neuroinflammation"},{"key":"2090_CR57","doi-asserted-by":"crossref","unstructured":"Trivedi MK, Mondal S, Gnagwar M, Jana S. Anti-inflammatory potential of cannabidiol (CBD) on combination of caecal slurry, LPS, and E. coli-induced systemic inflammatory response syndrome (SIRS) in Sprague Dawley Rats. Inflammopharmacology. 2022:1\u20138.","DOI":"10.1007\/s10787-021-00901-z"},{"key":"2090_CR58","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110745","volume":"123","author":"ME Matias","year":"2023","unstructured":"Matias ME, Radulski DR, da Silva DR, et al. Involvement of cannabinoid receptors and neuroinflammation in early sepsis: implications for posttraumatic stress disorder. Int Immunopharmacol. 2023;123:110745.","journal-title":"Int Immunopharmacol"},{"key":"2090_CR59","doi-asserted-by":"crossref","first-page":"1147520","DOI":"10.3389\/fimmu.2023.1147520","volume":"14","author":"M P\u00e9rez-Diego","year":"2023","unstructured":"P\u00e9rez-Diego M, Angelina A, Mart\u00edn-Cruz L, et al. Cannabinoid WIN55, 212\u20132 reprograms monocytes and macrophages to inhibit LPS-induced inflammation. Front Immunol. 2023;14:1147520.","journal-title":"Front Immunol"},{"key":"2090_CR60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176092","volume":"959","author":"CF Souza","year":"2023","unstructured":"Souza CF, Borges LB, Oliveira FRMB, et al. Cannabinoid CB2 receptor agonist reduces local and systemic inflammation associated with pneumonia-induced sepsis in mice. Eur J Pharmacol. 2023;959:176092.","journal-title":"Eur J Pharmacol"},{"key":"2090_CR61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2023.10.007","volume":"264","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhu Y, Chen S, et al. Activation of cannabinoid receptors 2 alleviates myocardial damage in cecal ligation and puncture-induced sepsis by inhibiting pyroptosis. Immunol Lett. 2023;264:17\u201324.","journal-title":"Immunol Lett"},{"key":"2090_CR62","volume":"123","author":"FZ Zhao","year":"2023","unstructured":"Zhao FZ, Gu WJ, Li LZ, et al. Cannabinoid receptor 2 alleviates sepsis-associated acute lung injury by modulating maturation of dendritic cells. Int Immunopharmacol. 2023;123:110771.","journal-title":"Int Immunopharmacol"},{"key":"2090_CR63","volume":"1828","author":"FF Gava","year":"2024","unstructured":"Gava FF, De Carli RJ, Stork S, et al. Cannabidiol effect on long-term brain alterations in septic rats: involvement of PPAR\u03b3 activation. Brain Res. 2024;1828:148771.","journal-title":"Brain Res"},{"key":"2090_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-024-03391-2","author":"\u0130 \u0130lhan","year":"2024","unstructured":"\u0130lhan \u0130, Asci H, Ozmen O, et al. The renoprotective effects of cannabidiol on lipopolysaccharide-induced systemic inflammation model of rats. Naunyn Schmiedebergs Arch Pharmacol. 2024. https:\/\/doi.org\/10.1007\/s00210-024-03391-2.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"2090_CR65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.31887\/DCNS.2020.22.3\/fthibaut","volume":"22","author":"F Thibaut","year":"2020","unstructured":"Thibaut F, Hoehe MR. Cannabinoids: for better and for worse. Dialogues Clin Neurosci. 2020;22(3):201\u20134.","journal-title":"Dialogues Clin Neurosci"},{"issue":"12","key":"2090_CR66","volume":"103","author":"AA Ekici","year":"2024","unstructured":"Ekici AA, Kisa A, Turhan SO. The evolution of sepsis publications and global productivity: a bibliometric analysis between 1980 and 2020. Medicine (Baltimore). 2024;103(12):e37380.","journal-title":"Medicine (Baltimore)"},{"key":"2090_CR67","unstructured":"Directive of Protection of Animals Used for Scientific Purposes. In: The dictionary of substances and their effects. Royal Society of Chemistry. 2010. Available online: https:\/\/eur-lex.europa.eu\/eli\/dir\/2010\/63\/oj\/eng. Accessed 27 Mar 2025."},{"key":"2090_CR68","unstructured":"Animal Welfare Act. In: The dictionary of substances and their effects. Royal Society of Chemistry. Available online: https:\/\/www.nal.usda.gov\/animal-health-and-welfare\/animal-welfare-act. Accessed 27 Mar 2025."},{"key":"2090_CR69","unstructured":"Lei N\u00b0 11.794\/2008. In: The dictionary of substances and their effects. Royal Society of Chemistry. Available online: https:\/\/www.planalto.gov.br\/ccivil_03\/_ato2007-2010\/2008\/lei\/l11794.htm. Accessed 27 Mar 2025."},{"key":"2090_CR70","unstructured":"Australian code for the care and use of animals for scientific purposes. In: The dictionary of substances and their effects. Royal Society of Chemistry. Available online: https:\/\/www.nhmrc.gov.au\/about-us\/publications\/australian-code-care-and-use-animals-scientific-purposes. Accessed 27 Mar 2025."},{"issue":"1","key":"2090_CR71","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4161\/viru.26083","volume":"5","author":"MP Fink","year":"2014","unstructured":"Fink MP. Animal models of sepsis. Virulence. 2014;5(1):143\u201353.","journal-title":"Virulence"},{"issue":"1","key":"2090_CR72","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/0192623316672743","volume":"45","author":"K Colman","year":"2017","unstructured":"Colman K. Impact of the genetics and source of preclinical safety animal models on study design, results, and interpretation. Toxicol Pathol. 2017;45(1):94\u2013106.","journal-title":"Toxicol Pathol"},{"issue":"1","key":"2090_CR73","first-page":"1","volume":"65","author":"I Gahima","year":"2021","unstructured":"Gahima I, Twizeyimana E, Gonzales EL, Remonde CG, Jeon SJ, Shin CY. Strain, age, and gender differences in response to lipopolysaccharide (LPS) animal model of sepsis in mice. J Pharm Pharm Sci. 2021;65(1):1\u20136.","journal-title":"J Pharm Pharm Sci"},{"issue":"10","key":"2090_CR74","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102176","volume":"18","author":"S Steven","year":"2017","unstructured":"Steven S, Dib M, Roohani S, Kashani F, M\u00fcnzel T, Daiber A. Time response of oxidative\/nitrosative stress and inflammation in LPS-induced endotoxaemia\u2014a comparative study of mice and rats. Int J Mol Sci. 2017;18(10):2176.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2090_CR75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1086\/649557","volume":"201","author":"HS Warren","year":"2010","unstructured":"Warren HS, Fitting C, Hoff E, Adib-Conquy M, Beasley-Topliffe L, Tesini B, et al. Resilience to bacterial infection: difference between species could be due to proteins in serum. J Infect Dis. 2010;201(2):223\u201332.","journal-title":"J Infect Dis"},{"issue":"7","key":"2090_CR76","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/FBP.0b013e3282eff0e8","volume":"18","author":"RN Hughes","year":"2007","unstructured":"Hughes RN. Sex does matter: comments on the prevalence of male-only investigations of drug effects on rodent behaviour. Behav Pharmacol. 2007;18(7):583\u20139.","journal-title":"Behav Pharmacol"},{"issue":"1","key":"2090_CR77","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/FBP.0000000000000410","volume":"30","author":"RN Hughes","year":"2019","unstructured":"Hughes RN. Sex still matters: has the prevalence of male-only studies of drug effects on rodent behaviour changed during the past decade? Behav Pharmacol. 2019;30(1):95\u20139.","journal-title":"Behav Pharmacol"},{"issue":"2","key":"2090_CR78","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0023677216653984","volume":"51","author":"SJ Jackson","year":"2017","unstructured":"Jackson SJ, Andrews N, Ball D, Bellantuono I, Gray J, Hachoumi L, et al. Does age matter? The impact of rodent age on study outcomes. Lab Anim. 2017;51(2):160\u20139.","journal-title":"Lab Anim"},{"key":"2090_CR79","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1590\/S1677-54492011000400001","volume":"10","author":"HA Miot","year":"2011","unstructured":"Miot HA. Sample size in clinical and experimental trials. J Vasc Bras. 2011;10:275\u20138.","journal-title":"J Vasc Bras"},{"issue":"2","key":"2090_CR80","doi-asserted-by":"crossref","first-page":"479","DOI":"10.52312\/jdrs.2022.719","volume":"33","author":"E Akkya","year":"2022","unstructured":"Akkya E, G\u00fcng\u00f6r HR. The dark side of the animal experiments. Joint Dis Relat Surg. 2022;33(2):479.","journal-title":"Joint Dis Relat Surg"},{"issue":"10","key":"2090_CR81","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd1854","volume":"4","author":"JA Buras","year":"2005","unstructured":"Buras JA, Holzmann B, Sitkovsly M. Animal models of sepsis: setting the stage. Nat Rev Drug Discov. 2005;4(10):854\u201365.","journal-title":"Nat Rev Drug Discov"},{"issue":"Suppl 1","key":"2090_CR82","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.5152\/eurasianjmed.2023.23364","volume":"55","author":"P Aydin","year":"2023","unstructured":"Aydin P, Bekmez H. Experimental sepsis models: advantages and limitations. Eurasian J Med. 2023;55(Suppl 1):S120.","journal-title":"Eurasian J Med"},{"issue":"1","key":"2090_CR83","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.110","volume":"131","author":"FV Sjaastad","year":"2020","unstructured":"Sjaastad FV, Jensen IJ, Berton RR, Badovinac VP, Griffith TS. Inducing experimental polymicrobial sepsis by cecal ligation and puncture. Curr Protoc Immunol. 2020;131(1):e110.","journal-title":"Curr Protoc Immunol"},{"issue":"1","key":"2090_CR84","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","volume":"24","author":"M Bauer","year":"2020","unstructured":"Bauer M, Gerlach H, Vogelmann T, et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019\u2014results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239.","journal-title":"Crit Care"},{"issue":"1","key":"2090_CR85","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12879-018-3156-z","volume":"18","author":"D Sinapidis","year":"2018","unstructured":"Sinapidis D, Kosmas V, Vittoros V, et al. Progression into sepsis: an individualized process varying by the interaction of comorbidities with the underlying infection. BMC Infect Dis. 2018;18(1):242.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"2090_CR86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005282","volume":"16","author":"SE Lazic","year":"2018","unstructured":"Lazic SE, Clarke-Williams CJ, Munaf\u00f2 MR. What exactly is \u2018N\u2019 in cell culture and animal experiments? PLoS Biol. 2018;16(4):e2005282.","journal-title":"PLoS Biol"},{"issue":"1","key":"2090_CR87","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40635-025-00715-1","volume":"13","author":"B Jacobs","year":"2025","unstructured":"Jacobs B, Derese I, Derde S, et al. A murine model of acute and prolonged abdominal sepsis, supported by intensive care, reveals time-dependent metabolic alterations in the heart. Intensive Care Med Exp. 2025;13(1):6.","journal-title":"Intensive Care Med Exp"},{"issue":"11","key":"2090_CR88","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.3390\/ijms24119578","volume":"24","author":"L Cai","year":"2023","unstructured":"Cai L, Rodgers E, Schoenmann N, et al. Advances in rodent experimental models of sepsis. Int J Mol Sci. 2023;24(11):9578.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2090_CR89","first-page":"120","volume":"58","author":"JA Nemzek","year":"2008","unstructured":"Nemzek JA, Hugunin K, Opp MR. Modeling sepsis in the laboratory: merging sound science with animal well-being. Comp Med. 2008;58(2):120\u20138.","journal-title":"Comp Med"},{"issue":"1","key":"2090_CR90","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bjae.2018.09.006","volume":"19","author":"M Charlton","year":"2019","unstructured":"Charlton M, Thompson JP. Pharmacokinetics in sepsis. BJA Educ. 2019;19(1):7\u201313.","journal-title":"BJA Educ"},{"key":"2090_CR91","doi-asserted-by":"crossref","unstructured":"Tai S, Fantegrossi WE. Pharmacological and toxicological effects of synthetic cannabinoids and their metabolites. Neuropharmacology of New Psychoactive Substances (NPS) The Science Behind the Headlines. 2016:249\u2013262.","DOI":"10.1007\/7854_2016_60"},{"issue":"5","key":"2090_CR92","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/10408444.2020.1762539","volume":"50","author":"VL Alves","year":"2020","unstructured":"Alves VL, Gon\u00e7alves JL, Aguiar J, et al. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review. Crit Rev Toxicol. 2020;50(5):359\u201382.","journal-title":"Crit Rev Toxicol"},{"key":"2090_CR93","unstructured":"Kelly BF, Nappe, TM. Cannabinoid toxicity. 2018."},{"key":"2090_CR94","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1002\/jcph.1871","volume":"61","author":"JD Brown","year":"2021","unstructured":"Brown JD, Rivera KJ, Hernandez LYC, et al. Natural and synthetic cannabinoids: pharmacology, uses, adverse drug events, and drug interactions. J Clin Pharmacol. 2021;61:S37\u201352.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"2090_CR95","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3940(92)90679-2","volume":"140","author":"A Szallasi","year":"1992","unstructured":"Szallasi A, Blumberg PM. Vanilloid receptor loss in rat sensory ganglia associated with long term desensitization to resiniferatoxin. Neurosci Lett. 1992;140(1):51\u20134.","journal-title":"Neurosci Lett"},{"issue":"A","key":"2090_CR96","doi-asserted-by":"crossref","first-page":"15A","DOI":"10.1155\/2005\/242516","volume":"10","author":"IJ McGilveray","year":"2005","unstructured":"McGilveray IJ. Pharmacokinetics of cannabinoids. Pain Res Manag. 2005;10(A):15A-22A.","journal-title":"Pain Res Manag"},{"issue":"2","key":"2090_CR97","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/CNQ.0000000000000352","volume":"44","author":"S Leviner","year":"2021","unstructured":"Leviner S. Post\u2013sepsis syndrome. Crit Care Nurs Q. 2021;44(2):182\u20136.","journal-title":"Crit Care Nurs Q"},{"issue":"2","key":"2090_CR98","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jemermed.2006.05.008","volume":"31","author":"M Raghavan","year":"2006","unstructured":"Raghavan M, Marik PE. Management of sepsis during the early \u201cgolden hours.\u201d J Emerg Med. 2006;31(2):185\u201399.","journal-title":"J Emerg Med"},{"key":"2090_CR99","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00063-013-0300-9","volume":"109","author":"T Chaudhary","year":"2014","unstructured":"Chaudhary T, Hohenstein C, Bayer O. The golden hour of sepsis: initial therapy should start in the prehospital setting. Med Klin Intensivmed Notfmed. 2014;109:104\u20138.","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"5","key":"2090_CR100","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1089\/can.2022.0046","volume":"8","author":"I \u0160ahinovi\u0107","year":"2023","unstructured":"\u0160ahinovi\u0107 I, Mandi\u0107 S, Mihi\u0107 D, Duvnjak M, Loinjak D, Sabadi D, et al. Endocannabinoids, anandamide and 2-arachidonoylglycerol, as prognostic markers of sepsis outcome and complications. Cannabis Cannabinoid Res. 2023;8(5):802\u201311.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"8","key":"2090_CR101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084204","volume":"25","author":"NM Blebea","year":"2024","unstructured":"Blebea NM, Pricopie AI, Vlad RA, Hancu G. Phytocannabinoids: exploring pharmacological profiles and their impact on therapeutical use. Int J Mol Sci. 2024;25(8):4204.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2090_CR102","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/cpt.563","volume":"101","author":"R Le Boisselier","year":"2017","unstructured":"Le Boisselier R, Alexandre J, Lelong-Boulouard V, Debruyne D. Focus on cannabinoids and synthetic cannabinoids. Clin Pharmacol Ther. 2017;101(2):220\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"2090_CR103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-019-0132-z","volume":"26","author":"Z Mostel","year":"2020","unstructured":"Mostel Z, Perl A, Marck MF, Mehdi SF, Lowell B, Bathija S, et al. Post-sepsis syndrome\u2013an evolving entity that afflicts survivors of sepsis. Mol Med. 2020;26:1\u201314.","journal-title":"Mol Med"},{"issue":"58","key":"2090_CR104","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jncimonographs\/lgab009","volume":"2021","author":"ZD Cooper","year":"2021","unstructured":"Cooper ZD, Abrams DI, Gust S, Salicrup A, Throckmorton DC. Challenges for clinical cannabis and cannabinoid research in the United States. JNCI Monogr. 2021;2021(58):114\u201322.","journal-title":"JNCI Monogr"},{"key":"2090_CR105","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465225","volume":"1732","author":"CH Inamassu","year":"2024","unstructured":"Inamassu CH, Silva LR, Marchioni C. Recent advances in the chromatographic analysis of endocannabinoids and phytocannabinoids in biological samples. J Chromatogr A. 2024;1732:465225.","journal-title":"J Chromatogr A"},{"issue":"21","key":"2090_CR106","volume":"20","author":"M Huang","year":"2019","unstructured":"Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019;20(21):5376.","journal-title":"Int J Mol Sci"},{"key":"2090_CR107","volume":"370","author":"SM Ali","year":"2023","unstructured":"Ali SM, Kolieb E, Imbaby S, Hagras AM, Arafat HEK, Kamel EM, et al. Acute toxic effects of new synthetic cannabinoid on brain: neurobehavioral and histological preclinical studies. Chem Biol Interact. 2023;370:110306.","journal-title":"Chem Biol Interact"},{"key":"2090_CR108","doi-asserted-by":"crossref","first-page":"23A","DOI":"10.1155\/2005\/763623","volume":"10","author":"P Beaulieu","year":"2005","unstructured":"Beaulieu P. Toxic effects of cannabis and cannabinoids: animal data. Pain Res Manag. 2005;10:23A-26A.","journal-title":"Pain Res Manag"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02090-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02090-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02090-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:53:38Z","timestamp":1767200018000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02090-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2090"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02090-9","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}],"article-number":"125"}}